Device type · HCG
Device, Neurovascular Embolization
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
HCG
Neurology
Device class
Class II
FDA decisions since 2015
45
510(k), De Novo and PMA
Adverse event reports
573
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Device, Neurovascular Embolization
- Product code
- HCG
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5950
- Specialty
- Neurology & Neurosurgery, Neurovascular
- FDA record
- Classification database entry for HCG
Latest FDA decisions
The 8 newest of 45 since 2015.
K262419 · Decided Aug 14, 2026 · 30 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
K261772 · Decided Jun 24, 2026 · 26 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
MicroPort NeuroTech (Shanghai) Co., Ltd.
K260351 · Decided May 20, 2026 · 106 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
K254221 · Decided Jan 27, 2026 · 29 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
- Target Detachable Coil510(k)
K252694 · Decided Dec 11, 2025 · 107 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
K251832 · Decided Oct 17, 2025 · 123 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
K252700 · Decided Sep 26, 2025 · 30 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
MicroPort NeuroTech (Shanghai) Co., Ltd.
K242154 · Decided Sep 30, 2024 · 69 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
Reports received
573
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
433
76% of reports
Injury reports
135
24% of reports
Death reports
4
0.7% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 50 | 4 | 1 | 0 |
| Jan 24 | 36 | 5 | 0 | 0 |
| Feb 24 | 34 | 9 | 0 | 0 |
| Mar 24 | 42 | 24 | 0 | 0 |
| Apr 24 | 34 | 11 | 0 | 0 |
| May 24 | 44 | 26 | 2 | 0 |
| Jun 24 | 22 | 8 | 0 | 0 |
| Jul 24 | 29 | 6 | 0 | 0 |
| Aug 24 | 39 | 9 | 1 | 0 |
| Sep 24 | 32 | 10 | 3 | 0 |
| Oct 24 | 25 | 10 | 2 | 0 |
| Nov 24 | 27 | 14 | 0 | 0 |
| Dec 24 | 35 | 12 | 1 | 0 |
| Jan 25 | 33 | 7 | 1 | 0 |
| Feb 25 | 28 | 7 | 0 | 0 |
| Mar 25 | 33 | 8 | 1 | 0 |
| Apr 25 | 45 | 14 | 0 | 0 |
| May 25 | 31 | 8 | 0 | 0 |
| Jun 25 | 34 | 7 | 0 | 0 |
| Jul 25 | 28 | 6 | 1 | 0 |
| Aug 25 | 38 | 4 | 0 | 0 |
| Sep 25 | 25 | 9 | 0 | 0 |
| Oct 25 | 38 | 8 | 1 | 0 |
| Nov 25 | 37 | 14 | 1 | 0 |
| Dec 25 | 53 | 22 | 3 | 0 |
| Jan 26 | 30 | 7 | 0 | 0 |
| Feb 26 | 34 | 8 | 0 | 0 |
| Mar 26 | 37 | 9 | 0 | 0 |
| Apr 26 | 39 | 5 | 0 | 0 |
| May 26 | 35 | 11 | 0 | 0 |
| Jun 26 | 45 | 5 | 0 | 0 |
| Jul 26 | 27 | 16 | 0 | 1 |
| Aug 26 | 30 | 10 | 0 | 0 |
| Sep 26 | 35 | 10 | 0 | 0 |
| Oct 26 | 31 | 18 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Premature Separation310
- Fracture56
- Adverse Event Without Identified Device or Use Problem52
- Migration41
- Physical Resistance/Sticking37
- Stretched27
- Difficult or Delayed Separation22
- Separation Failure21
- Expulsion15
- Failure to Advance13
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions473
- Foreign Body In Patient20
- Ruptured Aneurysm15
- Insufficient Information13
- Thrombosis/Thrombus11
- Aneurysm8
- Intracranial Hemorrhage8
- Hemorrhage/Blood Loss/Bleeding7
- Dyspareunia5
- Pelvic Pain5
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- INZONE DETACHMENT SYSTEM, REF: M00345100950Open, Classified
Z-2552-2026 · Started Apr 6, 2026 · Posted by FDA Jun 24, 2026
Reason given: Embolization coil detachment system devices may experience premature battery drain causing devices to: 1) Not power on; 2) Power on with faint audible and visual indicators; 3) Be unable to detach a coil as intended, which may necessitate medical intervention if the procedure must be completed with an alternative...
Cause as FDA categorized it: Component design/selection
Z-0434-2026 · Started Oct 2, 2025 · Posted by FDA Nov 13, 2025
Reason given: Detachable coils system may fail to detach, which could result in hemorrhagic and ischemic stroke, procedural delays, or the need for additional surgical intervention.
Cause as FDA categorized it: Under Investigation by firm
Z-1988-2025 · Started May 8, 2025 · Posted by FDA Jun 18, 2025
Reason given: Due to radiopaque (RO) marker was not visible during angiography and it was determined that the RO marker was not manufactured to specification.
Cause as FDA categorized it: Vendor change control
Z-1041-2024 · Started Jan 3, 2024 · Posted by FDA Feb 8, 2024
Reason given: Discoloration was identified along the delivery pusher which was attributed to corrosion of the hypotube. The material which caused the corrosion was identified as remnants of solder flux residue remaining on the hypotube component of the delivery pusher. Due to the location of the delivery pusher within the delivery...
Cause as FDA categorized it: Material/Component Contamination
- Optima Coil System Model Number OPTI0208CSS10, Model Number OPTI0308CSS10. Used in endovascular procedures.Open, Classified
Z-0103-2023 · Started Sep 7, 2022 · Posted by FDA Oct 20, 2022
Reason given: Product pouch label does not match up with carton label
Cause as FDA categorized it: Error in labeling
Z-1680-2022 · Started Jul 26, 2022
Reason given: Products were released to customers prior to the approval and release of a test report authorizing the use of an existing material from an alternate supplier.
Cause as FDA categorized it: Under Investigation by firm
- AXIUM DETACHABLE COIL SYSTEM REF QC-4-12-HELIX; Axium Detachable Coil System REF QC-10-30-3D;Open, Classified
Z-1261-2022 · Started Apr 27, 2022
Reason given: Due to incorrect size and configuration labeling of the detachable coil system.
Cause as FDA categorized it: Labeling Change Control
Z-0660-2022 · Started Jan 4, 2022
Reason given: Due to Label/Pouch mix-up. Pouches incorrectly labeled. Incorrect shelf carton label or pouch label due to inadequate manufacturing line clearance. As a result of this labeling mix-up, there is the possibility of inadvertently selecting the incorrect coil size for the procedure potentially causing some harms like...
Cause as FDA categorized it: Process control
Showing the 8 newest of 68 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.